Update date
31 Mar 2021
Shareable Research Card
This metric view shows APYX - Apyx Medical Corp earnings per share, basic and diluted history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest reported earnings per share, basic and diluted: -0.14. Open the source-backed page to compare this metric with the newest filing-backed context.
Update date
31 Mar 2021
Page type
Metric history
Latest period
Q1 2021
SEC-backed company facts were refreshed from filings filed on 07 May 2026.
Benchmark Context
Apyx Medical Corp sits in the bottom quarter of the current earnings per share, basic and diluted sample.
Compared with
Compared with 120 companies reporting earnings per share, basic and diluted in USD/shares. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 14x the current sample midpoint. Earnings Per Share, Basic and Diluted is down about 133% versus the comparable prior period.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
Latest period: Q1 2021. Period end: 31 Mar 2021. Units: USD/shares. Frequency: quarterly and annual.
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Source: SEC company facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare latest available Earnings Per Share, Basic and Diluted levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
Apyx Medical Corp appears at rank #116 in the latest comparison sample.
| Rank | Company | Latest value | Report period | Next step |
|---|---|---|---|---|
| 1 | BOSTON OMAHA Corp (boc) | 3.09 | Quarter - 31 Mar 2021 | Open BOSTON OMAHA Corp Earnings Per Share, Basic and Diluted |
| 2 | ENNIS, INC. (ebf) | 1.47 | Year - 29 Feb 2020 | Open ENNIS, INC. Earnings Per Share, Basic and Diluted |
| 3 | BiomX Inc. (phge) | 1.39 | Year - 31 Dec 2021 | Open BiomX Inc. Earnings Per Share, Basic and Diluted |
| 4 | Skillsoft Corp. (skil) | 1.28 | Quarter - 31 Mar 2021 | Open Skillsoft Corp. Earnings Per Share, Basic and Diluted |
| 5 | OneMedNet Corp (onmd) | 1.02 | Quarter - 30 Jun 2021 | Open OneMedNet Corp Earnings Per Share, Basic and Diluted |
| 6 | ALLEGRO MICROSYSTEMS, INC. (algm) | 0.96 | Quarter - 25 Sep 2020 | Open ALLEGRO MICROSYSTEMS, INC. Earnings Per Share, Basic and Diluted |
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2021 | -0.14 | -0.08 | -133% | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 12 May 2021 | 2021 | Q1 | |
| Q3 2020 | -0.11 | +0.02 | +15% | 01 Jul 2020 | 30 Sep 2020 | 10-Q | 09 Nov 2020 | 2020 | Q3 | |
| Q1 2020 | -0.47 | -0.06 | +0.11 | +65% | 01 Jan 2020 | 31 Mar 2020 | 10-Q | 12 May 2021 | 2021 | Q1 |
| Q4 2019 | -0.58 | -0.15 | 01 Oct 2019 | 31 Dec 2019 | 10-K | 31 Mar 2021 | 2020 | FY | ||
| Q3 2019 | -0.13 | 01 Jul 2019 | 30 Sep 2019 | 10-Q | 09 Nov 2020 | 2020 | Q3 | |||
| Q2 2019 | -0.13 | 01 Apr 2019 | 30 Jun 2019 | 10-K | 31 Mar 2020 | 2019 | FY | |||
| Q1 2019 | -0.17 | -0.14 | -467% | 01 Jan 2019 | 31 Mar 2019 | 10-Q/A | 08 May 2020 | 2019 | Q1 | |
| Q1 2018 | -0.03 | 01 Jan 2018 | 31 Mar 2018 | 10-Q/A | 08 May 2020 | 2019 | Q1 |
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2020 | -0.35 | +0.23 | +40% | 01 Jan 2020 | 31 Dec 2020 | 10-K | 31 Mar 2021 | 2020 | FY |
| 2019 | -0.58 | -2.44 | -131% | 01 Jan 2019 | 31 Dec 2019 | 10-K | 31 Mar 2021 | 2020 | FY |
| 2018 | 1.86 | +2.03 | 01 Jan 2018 | 31 Dec 2018 | 10-K | 14 Mar 2019 | 2018 | FY | |
| 2017 | -0.17 | -0.02 | -13% | 01 Jan 2017 | 31 Dec 2017 | 10-K | 14 Mar 2019 | 2018 | FY |
| 2016 | -0.15 | 01 Jan 2016 | 31 Dec 2016 | 10-K | 14 Mar 2019 | 2018 | FY |